Research by Mark McCarty and James DiNicolantonio Recognized by AAAS

On 24 Feb 2020, the American Association for the Advancement of Science (AAAS) issued a press release citing an article describing the work of CLF Founder, Mark McCarty, together with his co-author James DiNicolantonio, pointing the way toward a practical nutraceutical strategy for coping with RNA virus infections, including influenza and coronavirus. More particularly, the authors disclose that nutraceuticals that have anti-Nox2 activity also have potential for boosting the type 1 interferon response to RNA viruses, including influenza and coronavirus. The work is scheduled for publication in Progress in Cardiovascular Diseases.